![](https://unclineberger.org/wp-content/uploads/sites/867/2020/03/Serody_dotti_savoldo_2-600x400.jpg)
January 25, 2021
European Medicines Agency awards priority designation for Hodgkin lymphoma CAR-T therapy
The European Medicines Agency granted priority medicines designation to Tessa Therapeutics’ CD30 targeted CAR-T therapy for patients with relapsed or refractory Hodgkin lymphoma.